Hand Sanitizer Gel Dispenser
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global S1P Receptor Modulator Drugs Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Fingolimod 1.2.3 Ozanimod 1.2.4 Siponimod 1.2.5 Others 1.3 Market by Application 1.3.1 Global S1P Receptor Modulator Drugs Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Hospital Pharmacies 1.3.3 Retail Pharmacies 1.3.4 Online Pharmacies 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global S1P Receptor Modulator Drugs Market Perspective (2017-2028) 2.2 S1P Receptor Modulator Drugs Growth Trends by Region 2.2.1 S1P Receptor Modulator Drugs Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 S1P Receptor Modulator Drugs Historic Market Size by Region (2017-2022) 2.2.3 S1P Receptor Modulator Drugs Forecasted Market Size by Region (2023-2028) 2.3 S1P Receptor Modulator Drugs Market Dynamics 2.3.1 S1P Receptor Modulator Drugs Industry Trends 2.3.2 S1P Receptor Modulator Drugs Market Drivers 2.3.3 S1P Receptor Modulator Drugs Market Challenges 2.3.4 S1P Receptor Modulator Drugs Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top S1P Receptor Modulator Drugs Players by Revenue 3.1.1 Global Top S1P Receptor Modulator Drugs Players by Revenue (2017-2022) 3.1.2 Global S1P Receptor Modulator Drugs Revenue Market Share by Players (2017-2022) 3.2 Global S1P Receptor Modulator Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by S1P Receptor Modulator Drugs Revenue 3.4 Global S1P Receptor Modulator Drugs Market Concentration Ratio 3.4.1 Global S1P Receptor Modulator Drugs Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by S1P Receptor Modulator Drugs Revenue in 2021 3.5 S1P Receptor Modulator Drugs Key Players Head office and Area Served 3.6 Key Players S1P Receptor Modulator Drugs Product Solution and Service 3.7 Date of Enter into S1P Receptor Modulator Drugs Market 3.8 Mergers & Acquisitions, Expansion Plans 4 S1P Receptor Modulator Drugs Breakdown Data by Type 4.1 Global S1P Receptor Modulator Drugs Historic Market Size by Type (2017-2022) 4.2 Global S1P Receptor Modulator Drugs Forecasted Market Size by Type (2023-2028) 5 S1P Receptor Modulator Drugs Breakdown Data by Application 5.1 Global S1P Receptor Modulator Drugs Historic Market Size by Application (2017-2022) 5.2 Global S1P Receptor Modulator Drugs Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America S1P Receptor Modulator Drugs Market Size (2017-2028) 6.2 North America S1P Receptor Modulator Drugs Market Size by Country (2017-2022) 6.3 North America S1P Receptor Modulator Drugs Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe S1P Receptor Modulator Drugs Market Size (2017-2028) 7.2 Europe S1P Receptor Modulator Drugs Market Size by Country (2017-2022) 7.3 Europe S1P Receptor Modulator Drugs Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific S1P Receptor Modulator Drugs Market Size (2017-2028) 8.2 Asia-Pacific S1P Receptor Modulator Drugs Market Size by Country (2017-2022) 8.3 Asia-Pacific S1P Receptor Modulator Drugs Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America S1P Receptor Modulator Drugs Market Size (2017-2028) 9.2 Latin America S1P Receptor Modulator Drugs Market Size by Country (2017-2022) 9.3 Latin America S1P Receptor Modulator Drugs Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa S1P Receptor Modulator Drugs Market Size (2017-2028) 10.2 Middle East & Africa S1P Receptor Modulator Drugs Market Size by Country (2017-2022) 10.3 Middle East & Africa S1P Receptor Modulator Drugs Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Novartis International AG 11.1.1 Novartis International AG Company Detail 11.1.2 Novartis International AG Business Overview 11.1.3 Novartis International AG S1P Receptor Modulator Drugs Introduction 11.1.4 Novartis International AG Revenue in S1P Receptor Modulator Drugs Business (2017-2022) 11.1.5 Novartis International AG Recent Development 11.2 Bristol Myers Squibb 11.2.1 Bristol Myers Squibb Company Detail 11.2.2 Bristol Myers Squibb Business Overview 11.2.3 Bristol Myers Squibb S1P Receptor Modulator Drugs Introduction 11.2.4 Bristol Myers Squibb Revenue in S1P Receptor Modulator Drugs Business (2017-2022) 11.2.5 Bristol Myers Squibb Recent Development 11.3 Pfizer Inc. 11.3.1 Pfizer Inc. Company Detail 11.3.2 Pfizer Inc. Business Overview 11.3.3 Pfizer Inc. S1P Receptor Modulator Drugs Introduction 11.3.4 Pfizer Inc. Revenue in S1P Receptor Modulator Drugs Business (2017-2022) 11.3.5 Pfizer Inc. Recent Development 11.4 Sanofi SA 11.4.1 Sanofi SA Company Detail 11.4.2 Sanofi SA Business Overview 11.4.3 Sanofi SA S1P Receptor Modulator Drugs Introduction 11.4.4 Sanofi SA Revenue in S1P Receptor Modulator Drugs Business (2017-2022) 11.4.5 Sanofi SA Recent Development 11.5 Merck & Co., Inc. 11.5.1 Merck & Co., Inc. Company Detail 11.5.2 Merck & Co., Inc. Business Overview 11.5.3 Merck & Co., Inc. S1P Receptor Modulator Drugs Introduction 11.5.4 Merck & Co., Inc. Revenue in S1P Receptor Modulator Drugs Business (2017-2022) 11.5.5 Merck & Co., Inc. Recent Development 11.6 Biogen Inc. 11.6.1 Biogen Inc. Company Detail 11.6.2 Biogen Inc. Business Overview 11.6.3 Biogen Inc. S1P Receptor Modulator Drugs Introduction 11.6.4 Biogen Inc. Revenue in S1P Receptor Modulator Drugs Business (2017-2022) 11.6.5 Biogen Inc. Recent Development 11.7 Roche Holding AG 11.7.1 Roche Holding AG Company Detail 11.7.2 Roche Holding AG Business Overview 11.7.3 Roche Holding AG S1P Receptor Modulator Drugs Introduction 11.7.4 Roche Holding AG Revenue in S1P Receptor Modulator Drugs Business (2017-2022) 11.7.5 Roche Holding AG Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
List of Tables Table 1. Global S1P Receptor Modulator Drugs Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Fingolimod Table 3. Key Players of Ozanimod Table 4. Key Players of Siponimod Table 5. Key Players of Others Table 6. Global S1P Receptor Modulator Drugs Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global S1P Receptor Modulator Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 8. Global S1P Receptor Modulator Drugs Market Size by Region (2017-2022) & (US$ Million) Table 9. Global S1P Receptor Modulator Drugs Market Share by Region (2017-2022) Table 10. Global S1P Receptor Modulator Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 11. Global S1P Receptor Modulator Drugs Market Share by Region (2023-2028) Table 12. S1P Receptor Modulator Drugs Market Trends Table 13. S1P Receptor Modulator Drugs Market Drivers Table 14. S1P Receptor Modulator Drugs Market Challenges Table 15. S1P Receptor Modulator Drugs Market Restraints Table 16. Global S1P Receptor Modulator Drugs Revenue by Players (2017-2022) & (US$ Million) Table 17. Global S1P Receptor Modulator Drugs Market Share by Players (2017-2022) Table 18. Global Top S1P Receptor Modulator Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in S1P Receptor Modulator Drugs as of 2021) Table 19. Ranking of Global Top S1P Receptor Modulator Drugs Companies by Revenue (US$ Million) in 2021 Table 20. Global 5 Largest Players Market Share by S1P Receptor Modulator Drugs Revenue (CR5 and HHI) & (2017-2022) Table 21. Key Players Headquarters and Area Served Table 22. Key Players S1P Receptor Modulator Drugs Product Solution and Service Table 23. Date of Enter into S1P Receptor Modulator Drugs Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global S1P Receptor Modulator Drugs Market Size by Type (2017-2022) & (US$ Million) Table 26. Global S1P Receptor Modulator Drugs Revenue Market Share by Type (2017-2022) Table 27. Global S1P Receptor Modulator Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 28. Global S1P Receptor Modulator Drugs Revenue Market Share by Type (2023-2028) Table 29. Global S1P Receptor Modulator Drugs Market Size by Application (2017-2022) & (US$ Million) Table 30. Global S1P Receptor Modulator Drugs Revenue Market Share by Application (2017-2022) Table 31. Global S1P Receptor Modulator Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 32. Global S1P Receptor Modulator Drugs Revenue Market Share by Application (2023-2028) Table 33. North America S1P Receptor Modulator Drugs Market Size by Country (2017-2022) & (US$ Million) Table 34. North America S1P Receptor Modulator Drugs Market Size by Country (2023-2028) & (US$ Million) Table 35. Europe S1P Receptor Modulator Drugs Market Size by Country (2017-2022) & (US$ Million) Table 36. Europe S1P Receptor Modulator Drugs Market Size by Country (2023-2028) & (US$ Million) Table 37. Asia-Pacific S1P Receptor Modulator Drugs Market Size by Region (2017-2022) & (US$ Million) Table 38. Asia-Pacific S1P Receptor Modulator Drugs Market Size by Region (2023-2028) & (US$ Million) Table 39. Latin America S1P Receptor Modulator Drugs Market Size by Country (2017-2022) & (US$ Million) Table 40. Latin America S1P Receptor Modulator Drugs Market Size by Country (2023-2028) & (US$ Million) Table 41. Middle East & Africa S1P Receptor Modulator Drugs Market Size by Country (2017-2022) & (US$ Million) Table 42. Middle East & Africa S1P Receptor Modulator Drugs Market Size by Country (2023-2028) & (US$ Million) Table 43. Novartis International AG Company Detail Table 44. Novartis International AG Business Overview Table 45. Novartis International AG S1P Receptor Modulator Drugs Product Table 46. Novartis International AG Revenue in S1P Receptor Modulator Drugs Business (2017-2022) & (US$ Million) Table 47. Novartis International AG Recent Development Table 48. Bristol Myers Squibb Company Detail Table 49. Bristol Myers Squibb Business Overview Table 50. Bristol Myers Squibb S1P Receptor Modulator Drugs Product Table 51. Bristol Myers Squibb Revenue in S1P Receptor Modulator Drugs Business (2017-2022) & (US$ Million) Table 52. Bristol Myers Squibb Recent Development Table 53. Pfizer Inc. Company Detail Table 54. Pfizer Inc. Business Overview Table 55. Pfizer Inc. S1P Receptor Modulator Drugs Product Table 56. Pfizer Inc. Revenue in S1P Receptor Modulator Drugs Business (2017-2022) & (US$ Million) Table 57. Pfizer Inc. Recent Development Table 58. Sanofi SA Company Detail Table 59. Sanofi SA Business Overview Table 60. Sanofi SA S1P Receptor Modulator Drugs Product Table 61. Sanofi SA Revenue in S1P Receptor Modulator Drugs Business (2017-2022) & (US$ Million) Table 62. Sanofi SA Recent Development Table 63. Merck & Co., Inc. Company Detail Table 64. Merck & Co., Inc. Business Overview Table 65. Merck & Co., Inc. S1P Receptor Modulator Drugs Product Table 66. Merck & Co., Inc. Revenue in S1P Receptor Modulator Drugs Business (2017-2022) & (US$ Million) Table 67. Merck & Co., Inc. Recent Development Table 68. Biogen Inc. Company Detail Table 69. Biogen Inc. Business Overview Table 70. Biogen Inc. S1P Receptor Modulator Drugs Product Table 71. Biogen Inc. Revenue in S1P Receptor Modulator Drugs Business (2017-2022) & (US$ Million) Table 72. Biogen Inc. Recent Development Table 73. Roche Holding AG Company Detail Table 74. Roche Holding AG Business Overview Table 75. Roche Holding AG S1P Receptor Modulator Drugs Product Table 76. Roche Holding AG Revenue in S1P Receptor Modulator Drugs Business (2017-2022) & (US$ Million) Table 77. Roche Holding AG Recent Development Table 78. Research Programs/Design for This Report Table 79. Key Data Information from Secondary Sources Table 80. Key Data Information from Primary Sources List of Figures Figure 1. Global S1P Receptor Modulator Drugs Market Share by Type: 2021 VS 2028 Figure 2. Fingolimod Features Figure 3. Ozanimod Features Figure 4. Siponimod Features Figure 5. Others Features Figure 6. Global S1P Receptor Modulator Drugs Market Share by Application in 2021 & 2028 Figure 7. Hospital Pharmacies Case Studies Figure 8. Retail Pharmacies Case Studies Figure 9. Online Pharmacies Case Studies Figure 10. Others Case Studies Figure 11. S1P Receptor Modulator Drugs Report Years Considered Figure 12. Global S1P Receptor Modulator Drugs Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 13. Global S1P Receptor Modulator Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 14. Global S1P Receptor Modulator Drugs Market Share by Region: 2021 VS 2028 Figure 15. Global S1P Receptor Modulator Drugs Market Share by Players in 2021 Figure 16. Global Top S1P Receptor Modulator Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in S1P Receptor Modulator Drugs as of 2021) Figure 17. The Top 10 and 5 Players Market Share by S1P Receptor Modulator Drugs Revenue in 2021 Figure 18. North America S1P Receptor Modulator Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. North America S1P Receptor Modulator Drugs Market Share by Country (2017-2028) Figure 20. United States S1P Receptor Modulator Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Canada S1P Receptor Modulator Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Europe S1P Receptor Modulator Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. Europe S1P Receptor Modulator Drugs Market Share by Country (2017-2028) Figure 24. Germany S1P Receptor Modulator Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. France S1P Receptor Modulator Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. U.K. S1P Receptor Modulator Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Italy S1P Receptor Modulator Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Russia S1P Receptor Modulator Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Nordic Countries S1P Receptor Modulator Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Asia-Pacific S1P Receptor Modulator Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Asia-Pacific S1P Receptor Modulator Drugs Market Share by Region (2017-2028) Figure 32. China S1P Receptor Modulator Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Japan S1P Receptor Modulator Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. South Korea S1P Receptor Modulator Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Southeast Asia S1P Receptor Modulator Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. India S1P Receptor Modulator Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Australia S1P Receptor Modulator Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Latin America S1P Receptor Modulator Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Latin America S1P Receptor Modulator Drugs Market Share by Country (2017-2028) Figure 40. Mexico S1P Receptor Modulator Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Brazil S1P Receptor Modulator Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Middle East & Africa S1P Receptor Modulator Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Middle East & Africa S1P Receptor Modulator Drugs Market Share by Country (2017-2028) Figure 44. Turkey S1P Receptor Modulator Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. Saudi Arabia S1P Receptor Modulator Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 46. Novartis International AG Revenue Growth Rate in S1P Receptor Modulator Drugs Business (2017-2022) Figure 47. Bristol Myers Squibb Revenue Growth Rate in S1P Receptor Modulator Drugs Business (2017-2022) Figure 48. Pfizer Inc. Revenue Growth Rate in S1P Receptor Modulator Drugs Business (2017-2022) Figure 49. Sanofi SA Revenue Growth Rate in S1P Receptor Modulator Drugs Business (2017-2022) Figure 50. Merck & Co., Inc. Revenue Growth Rate in S1P Receptor Modulator Drugs Business (2017-2022) Figure 51. Biogen Inc. Revenue Growth Rate in S1P Receptor Modulator Drugs Business (2017-2022) Figure 52. Roche Holding AG Revenue Growth Rate in S1P Receptor Modulator Drugs Business (2017-2022) Figure 53. Bottom-up and Top-down Approaches for This Report Figure 54. Data Triangulation Figure 55. Key Executives Interviewed
Novartis International AG Bristol Myers Squibb Pfizer Inc. Sanofi SA Merck & Co., Inc. Biogen Inc. Roche Holding AG
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More